Highlights We examined the association of prenatal dioxins and polymorphism with birth size. Polymorphisms in 3 genes encoding dioxin-metabolizing enzymes were investigated. Polymorphisms were analyzed in 421 healthy pregnant Japanese women. Dioxin TEQ was associated with reduced birth weight reduction in the GSTM1 null genotype.
AbbreviationsAHR, aromatic hydrocarbon receptor; CYP, cytochrome P450; CYP1A1, cytochrome P450 1A1; dbSNP, database single nucleotide polymorphism; GSTM1, glutathione S-transferase mu 1; HRGC/HRMS, high-resolution gas chromatography/high-resolution mass spectrometry; PCB, polychlorinated biphenyl; PCDD, polychlorinated dibenzo-p-dioxin; PCDF, polychlorinated dibenzofuran; PenCB, pentachlorinated biphenyl; PenCDD, pentachlorinated dibenzo-p-dioxin; PenCDF, pentachlorinated dibenzofuran; TEQ, toxic equivalency; TetCDD, tetrachlorinated dibenzo-p-dioxin 3 Abstract Objectives: We investigated the effects of maternal polymorphisms in 3 genes encoding dioxin-metabolizing enzymes in relation to prenatal dioxin levels on infant birth size in Japan.
Methods:We examined the relationship between dioxin exposure and birth size in relation to the polymorphisms in the genes encoding aromatic hydrocarbon receptor (AHR [G>A, Arg554Lys]), cytochrome P450 (CYP) 1A1 (T6235C), and glutathione S-transferase mu 1 (GSTM1; Non-null/null) in 421 participants using multiple linear regression models.
Results:In mothers carrying the GSTM1 null genotype, a ten-fold increase in total dioxin toxic equivalency was correlated with a decrease in birth weight of -345 g (95% confidence interval: -584, -105).
Conclusions:We observed adverse effects of maternal GSTM1 null genotype on birth weight in the presence of dioxins exposure during pregnancy.